Integral Derivatives’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q3
Hold
0
270
2017
Q2
Hold
0
260
2017
Q1
Hold
0
300
2016
Q4
Hold
0
299
2014
Q1
Sell
-10,709
Closed -$81K 343
2013
Q4
$81K Buy
+10,709
New +$81K ﹤0.01% 325